Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in France.
Moulis G, Mahévas M, Viallard JF, Chèze S, Terriou L, Audia S, Moulinet T, Ebbo M, Gobert D, Robbins A, Gourguechon C, Graveleau J, Comont T, Saunier A, Faldlallah J, Carreiro M, Guilpain P, Gil H, Ruivard M, Magy-Bertrand N, Dossier A, Leveneur Y, Delbrel X, Anthony B, Lifermann F, Martin M, Ledoux MP, Roy-Péaud F, Chabbert L, Lapeyre-Mestre M, Sommet A, Zadro Y, Bonnotte B, Michel M, Godeau B; et le groupe des investigateurs de CARMEN‐France.
Moulis G, et al.
Am J Hematol. 2026 Apr;101(4):736-745. doi: 10.1002/ajh.70194. Epub 2026 Jan 8.
Am J Hematol. 2026.
PMID: 41504185